Transcription of Coverage and Coding of Continuous Glucose Monitors
{{id}} {{{paragraph}}}
Coverage and Coding of Continuous Glucose MonitorsHello and welcome to another edition of Medicare Minute MD. I m Dr. Robert Hoover, medical director at CGS Administrators, the Jurisdiction C DME MAC. Today I m go-ing to talk about a recent decision by the Centers for Medicare and Medicaid Services or CMS, that changed the Medicare Program s Coverage of Continuous Glucose monitor sys-tems. This change was effective January 12, 2017. What is a Continuous Glucose monitor system? A typical CGM system has three compo-nents a sensor that is inserted under the skin and measures Glucose levels; some way to transmit that measurement; and, some way to display those measurements. With most CGM systems on the market today, the sensor and transmitter are replaced on a regular basis. I mentioned January 12 and that s a key date here.
Dexcom G5 Mobile CGM system. It was the first CGM system that the FDA allowed to be marketed as a “non-adjunctive” CGM system, meaning it could serve as the primary de-vice to make therapy decisions. In other words, the FDA did not require a standard blood
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}